This Entrepreneur Built A Multimillion Dollar Company To Help Your Dog Live Longer | Forbes

Celine Halioua, who studied neuroscience at the University of Texas, Austin, and economics of gene therapeutics at Oxford, founded San Francisco– based biotech Cellular Longevity (known as Loyal) in 2019 to identify compounds that help prevent undue aging and cancer in dogs, which could also potentially help humans. One key advantage: It’s easier to get experimental drugs approved for the veterinary market than for humans. Her first anti-aging drug entering clinical trials next year targets a cellular mechanism hypothesized to mitigate mental and physical decline associated with age. The pre-revenue company has raised over $38 million in venture capital. “There’s never been a drug approved for aging for any species, dog or human,” Halioua says. “My core goal in life is to get the first drug approved.”

We published the first edition of the Forbes 30 Under 30 a decade ago, with one clear goal: to identify the new guard, the young innovators, trailblazers and disruptors remaking our world. That first list featured names like Kevin Systrom, whose company Instagram had only seven employees; Lena Dunham, who had yet to debut on HBO's Girls; Daniel Ek, who had just launched Spotify in the U.S.; journalist Ronan Farrow, years before he exposed Harvey Weinstein in the New Yorker; and actor Donald Glover, then mostly known as a cast member in the cult comedy Community.

Much of 2022 was being freshly created by this group back in 2012. Ten years from today, it’s a good bet we’ll all be living in a new world being imagined today by the 600 entrepreneurs, innovators and entertainers that make up our 10th Anniversary class.

Read more on Forbes

Subscribe to FORBES

Stay Connected

Forbes newsletters

Forbes on Facebook

Forbes Video on Twitter

Forbes Video on Instagram

More From Forbes

Forbes covers the intersection of entrepreneurship, wealth, technology, business and lifestyle with a focus on people and success.